← Back to Clinical Trials
Recruiting NCT07578051

NCT07578051 Impairment Oriented Versus Task Oriented Gait Training In Transfemoral Amputee Rehabilitation.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07578051
Status Recruiting
Phase
Sponsor Foundation University Islamabad
Condition Transfemoral Amputees
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2026-05-06
Primary Completion 2026-07-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
Impairment oriented (Group A)Task oriented (Group B)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2026-05-06 with a primary completion date of 2026-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study examines the comparison between Impairment Oriented versus Task Oriented Gait Training in Transfemoral Amputee Rehabilitation. A randomized controlled trial conducted with 40 participants divided into two groups .Both groups receive pre-gait training and corrective walking exercises for 10 days .

Eligibility Criteria

Inclusion Criteria: * Age 18-40 years * Unilateral transfemoral amputees * Cleared by physicians for participation in physical therapy * Willing Exclusion Criteria: * Residual limb complication that interfere with mobility * History of neurological disorders * Any joint complication in intact limb * Currently enrolled in another research study * Mild to severe cognitive impairment (MoCA) i.e , score less than 25 , Uncontrolled diabetes

Contact & Investigator

Central Contact

Saliha Bibi, DPT

✉ bibisaliha1293@gmail.com

📞 03171501156

Principal Investigator

Saliha Bibi, DPT

PRINCIPAL INVESTIGATOR

Foundation University Islamabad

Frequently Asked Questions

Who can join the NCT07578051 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Transfemoral Amputees. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07578051 currently recruiting?

Yes, NCT07578051 is actively recruiting participants. Contact the research team at bibisaliha1293@gmail.com for enrollment information.

Where is the NCT07578051 trial being conducted?

This trial is being conducted at Islamabad, Pakistan.

Who is sponsoring the NCT07578051 clinical trial?

NCT07578051 is sponsored by Foundation University Islamabad. The principal investigator is Saliha Bibi, DPT at Foundation University Islamabad. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology